Navigation Links
NeoGenomics Announces Executive Appointments
Date:12/4/2009

FORT MYERS, Fla., Dec. 4 /PRNewswire-FirstCall/ -- NeoGenomics, Inc. (OTC Bulletin Board: NGNM) announced today that Steven C. Jones has been appointed Executive Vice President, Finance and that George A. Cardoza has joined the company as Chief Financial Officer. Mr. Cardoza will be responsible for managing all internal financial affairs of the Company. In his new role, Mr. Jones will focus on developing strategic initiatives on behalf of NeoGenomics as well as continue to serve as the Company's Director of Investor Relations.

Mr. Cardoza most recently served as Chief Financial Officer of Protocol Global Solutions, Inc., a privately held international marketing company. Prior to joining Protocol Global Solutions in 2006, Mr. Cardoza was employed by Quest Diagnostics in a variety of financial roles of increasing responsibility. While at Quest Diagnostics, George served as Controller of the Central Region with responsibility for 11 major laboratories.

Douglas VanOort, Chairman and Chief Executive Officer, stated, "I am delighted to welcome George Cardoza to NeoGenomics. I had the privilege of working with George for eight years during my own time at Quest Diagnostics and he brings outstanding financial management skills to our company. We are also very pleased to have Steve Jones lead strategic initiatives for our company in addition to his role in Investor Relations. Steve has served as "Acting CFO" for the last seven years, and brings wealth of experience and strategic skills to his new role. We are deeply indebted to him for his dedication and many contributions to the growth and success of NeoGenomics."

About NeoGenomics, Inc.

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology and molecular genetic testing. Headquartered in Fort Myers, FL, NeoGenomics has labs in Nashville, TN, Irvine, CA and Fort Myers and services the needs of pathologists, oncologists, urologists, and hospitals throughout the United States. For additional information about NeoGenomics, visit http://www.neogenomics.org.

For more news and information on NeoGenomics, please visit www.IRGnews.com/coi/NGNM where you can find a fact sheet on the company, investor presentations, and more. Interested parties can also access additional investor relations material, including an investment profile and an equity research report, from Hawk Associates at http://www.hawkassociates.com or from the American Microcap Institute at http://www.americanmicrocapinstitute.com/ngnm/.

SOURCE NeoGenomics, Inc.


'/>"/>
SOURCE NeoGenomics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
2. NeoGenomics Announces Results for the 3rd Quarter 2007
3. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
4. NeoGenomics to Present at the Noble Financial Equity Conference
5. NeoGenomics Schedules Its Q3 2008 Earnings Release for November 6, 2008
6. NeoGenomics to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
7. NeoGenomics Appoints Douglas M. VanOort as Executive Chairman and Interim Chief Executive Officer
8. NeoGenomics Schedules its Q1 2009 Earnings Release for April 23, 2009
9. NeoGenomics, Inc. Reports First Quarter 2009 Financial Results
10. NeoGenomics to Present at Noble Financials 5th Annual Equity Conference on Monday, June 8th
11. NeoGenomics Schedules Its Q2 2009 Earnings Release for July 28, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis Labs sold 300 bottles ... AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these results while doing ... an over the counter heart healthy drink, can reduce Arterial Plaque, Lower Blood ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... growing as it continues developing an ANSI-approved, consensus-based American National Standard for ... plans to publish the first ANSI-approved GMP standard for dietary supplements this ...
(Date:3/29/2017)... ... March 29, 2017 , ... HealthCareMandA.com will host an ... 20, 2017, at 1:00 PM ET. A recording of the webinar will also be ... Series. , Home health and hospice companies are still popular targets for healthcare investors. ...
(Date:3/29/2017)... (PRWEB) , ... March 29, 2017 , ... ... of Gastrointestinal Oncology™ (SOGO™), a specialized continuing medical education conference for clinicians who ... at Intercontinental Time Square, New York. , The program will be led ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Tuesday, March 28, ... American public to take the Diabetes Risk Test to find out if they are ... Angeles World Airports will light up the evening sky by programming the LAX pylons ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... Research and Markets has announced the addition of the ... their offering. ... The ablation device global market is expected to grow at high ... Ablation is the minimally invasive therapeutic tissue excision procedure used ... removal, to the removal of abnormally conducting cardiac tissue in atrial ...
(Date:3/29/2017)... , March 29, 2017  Spiral Therapeutics, ... agreement with Bionure Farma, S.L. for the worldwide ... to BN119 in the field of otolaryngology for ... sales-based royalties. The agreement provides Spiral with ... with a differentiated product profile. Under the terms ...
(Date:3/29/2017)... 2017   Royal Philips (NYSE: PHG, ... and PathAI, a company that develops artificial intelligence ... to develop solutions that improve the precision and ... diseases. The partnership aims to build deep learning ... artificial intelligence to be applied to massive pathology ...
Breaking Medicine Technology: